| 1 | dual | 3,372 |
| 2 | triple | 2,423 |
| 3 | quadruple | 348 |
| 4 | multi | 155 |
| 5 | basal-bolus | 102 |
| 6 | gibbs | 87 |
| 7 | multisystemic | 84 |
| 8 | three-drug | 84 |
| 9 | two-drug | 73 |
| 10 | single-drug | 69 |
| 11 | triple-drug | 59 |
| 12 | combinational | 53 |
| 13 | expulsive | 42 |
| 14 | levofloxacin-based | 41 |
| 15 | yuzpe | 41 |
| 16 | time-based | 39 |
| 17 | four-drug | 37 |
| 18 | statin-fibrate | 37 |
| 19 | 3-drug | 33 |
| 20 | tacrolimus-based | 33 |
| 21 | bismuth-containing | 29 |
| 22 | cni-free | 28 |
| 23 | telaprevir-based | 28 |
| 24 | bismuth-based | 25 |
| 25 | levofloxacin-containing | 25 |
| 26 | clarithromycin-based | 23 |
| 27 | multitarget | 23 |
| 28 | symptom-guided | 23 |
| 29 | cyclosporine-based | 22 |
| 30 | ppi-based | 22 |
| 31 | csa-based | 20 |
| 32 | non-bismuth | 20 |
| 33 | efavirenz-containing | 18 |
| 34 | mdcf | 18 |
| 35 | temperature-time | 18 |
| 36 | everolimus-based | 17 |
| 37 | moxifloxacin-based | 17 |
| 38 | sirolimus-based | 17 |
| 39 | 4-drug | 16 |
| 40 | polysporin | 16 |
| 41 | statin-based | 16 |
| 42 | tenofovir-based | 16 |
| 43 | cni-based | 15 |
| 44 | 'triple | 14 |
| 45 | 2-drug | 14 |
| 46 | agent-based | 14 |
| 47 | schema-focused | 14 |
| 48 | zero-point | 14 |
| 49 | culture-guided | 13 |
| 50 | highly-active | 13 |
| 51 | isdn/hyd | 13 |
| 52 | perturbative | 13 |
| 53 | tac-based | 13 |
| 54 | caffeine-containing | 12 |
| 55 | handrim | 12 |
| 56 | low-activity | 12 |
| 57 | nrti-sparing | 12 |
| 58 | 5-drug | 11 |
| 59 | heparin-based | 11 |
| 60 | srl-based | 11 |
| 61 | taxane-platinum | 11 |
| 62 | boceprevir-based | 10 |
| 63 | citrate-based | 10 |
| 64 | five-drug | 10 |
| 65 | moxifloxacin-containing | 10 |
| 66 | noncaffeinated | 10 |
| 67 | peg-ifn/ribavirin | 10 |
| 68 | drv/r-based | 9 |
| 69 | fenofibrate-statin | 9 |
| 70 | furazolidone-based | 9 |
| 71 | i-one | 9 |
| 72 | mallinson | 9 |
| 73 | non-continuous | 9 |
| 74 | shu-needle | 9 |
| 75 | tvr-based | 9 |
| 76 | anti-hp | 8 |
| 77 | basal-prandial | 8 |
| 78 | clinician-directed | 8 |
| 79 | co-60 | 8 |
| 80 | esomeprazole-based | 8 |
| 81 | fränkel | 8 |
| 82 | hivnet-012 | 8 |
| 83 | lopinavir/ritonavir-containing | 8 |
| 84 | navel-warming | 8 |
| 85 | nnrti-containing | 8 |
| 86 | pritchard | 8 |
| 87 | ribavirin-free | 8 |
| 88 | tdf-containing | 8 |
| 89 | all-2 | 7 |
| 90 | basal/bolus | 7 |
| 91 | belatacept-based | 7 |
| 92 | constant-frequency | 7 |
| 93 | lansoprazole-based | 7 |
| 94 | p-containing | 7 |
| 95 | ribavirin-containing | 7 |
| 96 | stavudine-containing | 7 |
| 97 | zidovudine-based | 7 |
| 98 | zidovudine-containing | 7 |
| 99 | azt-substitution | 6 |
| 100 | lpv-r/ral | 6 |
| 101 | maraviroc-containing | 6 |
| 102 | non-mdr | 6 |
| 103 | nursing-implemented | 6 |
| 104 | physical/occupational | 6 |
| 105 | rifampin-containing | 6 |
| 106 | sulfonylurea-based | 6 |
| 107 | t4/t3 | 6 |
| 108 | udca-same | 6 |
| 109 | antihistamine/decongestant | 5 |
| 110 | bevacizumab+mfolfiri | 5 |
| 111 | ceramide-dominant | 5 |
| 112 | clopidogrel-induced | 5 |
| 113 | epoxygenase | 5 |
| 114 | feature-absent | 5 |
| 115 | ftbi/vp-16 | 5 |
| 116 | metronidazole-containing | 5 |
| 117 | ntrti-sparing | 5 |
| 118 | photofrin | 5 |
| 119 | pi/r-based | 5 |
| 120 | rabeprazole-based | 5 |
| 121 | rbv-free | 5 |
| 122 | statin-fenofibrate | 5 |
| 123 | tomatis | 5 |
| 124 | 'talking | 4 |
| 125 | bioactivity-integrated | 4 |
| 126 | cfc-containing | 4 |
| 127 | levofloxacin/amoxicillin/esomeprazole | 4 |
| 128 | liver-directed | 4 |
| 129 | macrolide-based | 4 |
| 130 | marbocyl | 4 |
| 131 | multi-treatment | 4 |
| 132 | non-cag | 4 |
| 133 | non-sena | 4 |
| 134 | nonbismuth | 4 |
| 135 | remittive | 4 |
| 136 | rmp-containing | 4 |
| 137 | rsv/rv | 4 |
| 138 | six-drug | 4 |
| 139 | strong-coupling | 4 |
| 140 | thalidomide-containing | 4 |
| 141 | vascular-targeted | 4 |
| 142 | β-blocker-based | 4 |
| 143 | 2-strand | 3 |
| 144 | 4-mm-diameter | 3 |
| 145 | anesthesiologist-administered | 3 |
| 146 | aspirin-based | 3 |
| 147 | atorvastatin-based | 3 |
| 148 | atzpodien | 3 |
| 149 | b-cell-targeted | 3 |
| 150 | birid | 3 |
| 151 | calcineurin-inhibitor-free | 3 |
| 152 | continuous-dosing | 3 |
| 153 | cox/5-lox | 3 |
| 154 | dual-agent | 3 |
| 155 | esoprazole-based | 3 |
| 156 | faceted | 3 |
| 157 | fluoroquinolone-containing | 3 |
| 158 | gemcitabine-containing | 3 |
| 159 | h-re | 3 |
| 160 | heat-generated | 3 |
| 161 | hnis/tdtomato | 3 |
| 162 | ics-laba | 3 |
| 163 | lamivudine-plus-adefovir | 3 |
| 164 | lt4-lt3 | 3 |
| 165 | midazolam-based | 3 |
| 166 | nevirapine-containing | 3 |
| 167 | niacin-statin | 3 |
| 168 | pill-based | 3 |
| 169 | renin- | 3 |
| 170 | resonance-type | 3 |
| 171 | ritonavir-containing | 3 |
| 172 | rtv-sparing | 3 |
| 173 | tdf/ftc-based | 3 |
| 174 | triple-agent | 3 |
| 175 | underdoped | 3 |
| 176 | uv-based | 3 |
| 177 | 'individualized | 2 |
| 178 | 20-mg/kg/day | 2 |
| 179 | anthracycline/taxane | 2 |
| 180 | arm+leg | 2 |
| 181 | auger-type | 2 |
| 182 | auricular-plaster | 2 |
| 183 | benidipine-based | 2 |
| 184 | bezafibrate-lovastatin | 2 |
| 185 | c-src/abl | 2 |
| 186 | carotenoid-based | 2 |
| 187 | chemotherapy/bevacizumab | 2 |
| 188 | cilostazol-based | 2 |
| 189 | cilostazol-optimized | 2 |
| 190 | clarithromycin-containing | 2 |
| 191 | clarithromycinbased | 2 |
| 192 | clopidogrel-only | 2 |
| 193 | co60 | 2 |
| 194 | codeine-based | 2 |
| 195 | combined-drug | 2 |
| 196 | conbination | 2 |
| 197 | csa-containing | 2 |
| 198 | cube-like | 2 |
| 199 | d4t-containing | 2 |
| 200 | dompé | 2 |
| 201 | fc-inactivated | 2 |
| 202 | fluid-conservative | 2 |
| 203 | fluid-liberal | 2 |
| 204 | furazolidone-containing | 2 |
| 205 | gem-containing | 2 |
| 206 | hsc-mediated | 2 |
| 207 | hsfa1a/b/d | 2 |
| 208 | hsfa1a/b/d/e | 2 |
| 209 | imidapril-based | 2 |
| 210 | imidazole-based | 2 |
| 211 | inh+emb-based | 2 |
| 212 | isoniazid-based | 2 |
| 213 | juice-making | 2 |
| 214 | levofloxacin-250 | 2 |
| 215 | light-to-electric | 2 |
| 216 | list-learning | 2 |
| 217 | mb-based | 2 |
| 218 | methylaminolaevulinate | 2 |
| 219 | monotherapy.the | 2 |
| 220 | multiplate-tailored | 2 |
| 221 | narrow-window | 2 |
| 222 | non-anaphylactogenic | 2 |
| 223 | non-cns-t | 2 |
| 224 | non-hbv-active | 2 |
| 225 | non-infiltrative | 2 |
| 226 | nonefavirenz-based | 2 |
| 227 | nrti-based | 2 |
| 228 | ocd-specific | 2 |
| 229 | opicapone-induced | 2 |
| 230 | penicillin-aminoglycoside | 2 |
| 231 | polar×semipolar | 2 |
| 232 | prasugrel-based | 2 |
| 233 | proline-induced | 2 |
| 234 | quinine-based | 2 |
| 235 | radiotherapy-hyperthermia | 2 |
| 236 | resistance-guided | 2 |
| 237 | rh-endostatin+dp | 2 |
| 238 | sanità-pulsed | 2 |
| 239 | sequential-concomitant | 2 |
| 240 | single/dual | 2 |
| 241 | ssri+t3 | 2 |
| 242 | statin-niacin | 2 |
| 243 | steroid-avoiding | 2 |
| 244 | t-cell-directed | 2 |
| 245 | t3-ssri | 2 |
| 246 | tamoxifen/everolimus | 2 |
| 247 | taxane-anthracycline-capecitabine | 2 |
| 248 | thrombin-specific | 2 |
| 249 | thymidine-sparing | 2 |
| 250 | triple-nucleoside | 2 |
| 251 | verteporfin-based | 2 |
| 252 | 'mindfulness | 1 |
| 253 | 'petra | 1 |
| 254 | 0.8× | 1 |
| 255 | 1470±690 | 1 |
| 256 | 16-min | 1 |
| 257 | 1q25.3/1p35.2 | 1 |
| 258 | 2.0-s-long | 1 |
| 259 | 21-7 | 1 |
| 260 | 3tc-based | 1 |
| 261 | 5-mci | 1 |
| 262 | a/cd36 | 1 |
| 263 | aa'3b4o12-type | 1 |
| 264 | abl/src | 1 |
| 265 | accelerated-dose | 1 |
| 266 | advagraf®-based | 1 |
| 267 | advocate®/advantage® | 1 |
| 268 | alfa-2a/rbv | 1 |
| 269 | amphotericin-based | 1 |
| 270 | ampicillin-sulbactam-based | 1 |
| 271 | anti-inflammatory/cardiovascular | 1 |
| 272 | anti-m3 | 1 |
| 273 | aprepitant-based | 1 |
| 274 | asunaprevir-based | 1 |
| 275 | awakening-time-treatment | 1 |
| 276 | azi-loaded | 1 |
| 277 | badal | 1 |
| 278 | bli-3/tsp-15/doxa-1 | 1 |
| 279 | bpi-based | 1 |
| 280 | carbon-neutral | 1 |
| 281 | category-matching | 1 |
| 282 | ccta-directed | 1 |
| 283 | cis-platinum-containing | 1 |
| 284 | clopidogrel-based | 1 |
| 285 | clr-based | 1 |
| 286 | cognitive-depletion | 1 |
| 287 | comedication/augmentation | 1 |
| 288 | componentn | 1 |
| 289 | continuous-sequential | 1 |
| 290 | cost/treatment | 1 |
| 291 | cxcr3-cxcr4 | 1 |
| 292 | darunavir/ritonavir-based | 1 |
| 293 | das-d. | 1 |
| 294 | das28-driven | 1 |
| 295 | dcl2/dcl3/dcl4 | 1 |
| 296 | ddp-based | 1 |
| 297 | decreased/normal | 1 |
| 298 | denominator-their | 1 |
| 299 | depression/drug | 1 |
| 300 | dhp-based | 1 |
| 301 | diadochokinetic | 1 |
| 302 | disparity-discrimination | 1 |
| 303 | dispersed-subtractive | 1 |
| 304 | dolutegravir-containing | 1 |
| 305 | drug-intramuscular | 1 |
| 306 | dynamic-dosing | 1 |
| 307 | edahb-mediated | 1 |
| 308 | edta-2k | 1 |
| 309 | energy-favorable | 1 |
| 310 | epirubicin-cisplatin-infusional | 1 |
| 311 | eri-1 | 1 |
| 312 | excipient-free | 1 |
| 313 | exhitbit | 1 |
| 314 | face-rating | 1 |
| 315 | fad3fad7fad8 | 1 |
| 316 | faldaprevir-pegifn-rbv | 1 |
| 317 | feature-listing | 1 |
| 318 | fiber/vitamin | 1 |
| 319 | first-generation-pi | 1 |
| 320 | first-person-shooter | 1 |
| 321 | fixed-period | 1 |
| 322 | flanker-stop-signal | 1 |
| 323 | flanker/nogo | 1 |
| 324 | flare-only | 1 |
| 325 | fluoropyrimidine/cisplatin | 1 |
| 326 | food-reinforcement | 1 |
| 327 | function-learning | 1 |
| 328 | gap-overlap | 1 |
| 329 | goalkeeping | 1 |
| 330 | gromos96 | 1 |
| 331 | hair/plasma | 1 |
| 332 | haptic-identification | 1 |
| 333 | hill-walking | 1 |
| 334 | house-matching | 1 |
| 335 | il28β-guided | 1 |
| 336 | immunsuppressive | 1 |
| 337 | indefinite-term | 1 |
| 338 | infusion-only | 1 |
| 339 | inter-association | 1 |
| 340 | j-tech | 1 |
| 341 | ldl-c/non-hdl | 1 |
| 342 | letter-updating | 1 |
| 343 | levofloxacin-free | 1 |
| 344 | levofloxacin-tinidazole-based | 1 |
| 345 | levofloxacin/amoxicillin/proton-pump | 1 |
| 346 | lexical-decision | 1 |
| 347 | local-selection | 1 |
| 348 | locomotion-to-reach | 1 |
| 349 | lx4211-mediated | 1 |
| 350 | m05-2x/cc-pvtz | 1 |
| 351 | magnesium-sufentanil | 1 |
| 352 | magnitude-comparison | 1 |
| 353 | mdr/non-mdr | 1 |
| 354 | melphalan-alone | 1 |
| 355 | meop | 1 |
| 356 | mericitabine-containing | 1 |
| 357 | metformin+pioglitazone+glibenclamide | 1 |
| 358 | metronidazole.a | 1 |
| 359 | micro-electrical | 1 |
| 360 | more-predictable | 1 |
| 361 | morphine-promethazine | 1 |
| 362 | multiple-object-tracking | 1 |
| 363 | neoadjuvant/adjuvant/chemoprevention | 1 |
| 364 | nightwork | 1 |
| 365 | non-basal | 1 |
| 366 | non-bismuth-based | 1 |
| 367 | non-ketamine-containing | 1 |
| 368 | non-platinum/non-taxane | 1 |
| 369 | non-pld | 1 |
| 370 | non-thermal-based | 1 |
| 371 | nonfurazolidone | 1 |
| 372 | nonnewer | 1 |
| 373 | nonthienopyridine | 1 |
| 374 | outcomes.balanced | 1 |
| 375 | paired-click | 1 |
| 376 | parasitism-adapted | 1 |
| 377 | pdxg | 1 |
| 378 | peg-ifna/rbv | 1 |
| 379 | peg/lam | 1 |
| 380 | pfdhfr/pfdhps | 1 |
| 381 | photofrin-mediated | 1 |
| 382 | picture-definition | 1 |
| 383 | picture-perception | 1 |
| 384 | plus/luxacore | 1 |
| 385 | pmdi-spacer | 1 |
| 386 | ppi-amoxicillin-levofloxacin | 1 |
| 387 | ppi-clarithromycin-metronidazole | 1 |
| 388 | ppi-triple | 1 |
| 389 | praise-related | 1 |
| 390 | pre-highly-active | 1 |
| 391 | probability-trade-off | 1 |
| 392 | purevision™ | 1 |
| 393 | pushing/pulling | 1 |
| 394 | radio/chemoradiotherapy | 1 |
| 395 | raltegravir-containing | 1 |
| 396 | raltegravir-inclusive | 1 |
| 397 | reach-and-return | 1 |
| 398 | response-priming | 1 |
| 399 | restrictive-deferred | 1 |
| 400 | reversal/extinction | 1 |
| 401 | rifabutin-amoxicillin-ppi | 1 |
| 402 | sarpogrelate-based | 1 |
| 403 | self-affirmation/control | 1 |
| 404 | serotonin-preferring | 1 |
| 405 | sham‟ | 1 |
| 406 | shoma | 1 |
| 407 | side-step-cutting | 1 |
| 408 | six-pulse | 1 |
| 409 | smartmix | 1 |
| 410 | smoking-craving | 1 |
| 411 | smtp-7-induced | 1 |
| 412 | solvatoemissive | 1 |
| 413 | spatial-context-discrimination | 1 |
| 414 | specific-sprinter | 1 |
| 415 | src/abl1 | 1 |
| 416 | star-tracing | 1 |
| 417 | sti-shiv | 1 |
| 418 | sti-treatment | 1 |
| 419 | subcitrate-based | 1 |
| 420 | surf- | 1 |
| 421 | sustained-attention-to-response | 1 |
| 422 | symbol-disambiguation | 1 |
| 423 | symbol-learning | 1 |
| 424 | synchronization-continuation | 1 |
| 425 | t3-ssris | 1 |
| 426 | ta-based | 1 |
| 427 | tactile-proprioceptive | 1 |
| 428 | taste-rating | 1 |
| 429 | telemetry-enabled | 1 |
| 430 | temsirolimus-containing | 1 |
| 431 | testing.a | 1 |
| 432 | thienopyridine-based | 1 |
| 433 | time-estimation | 1 |
| 434 | tower-of-hanoi | 1 |
| 435 | treatment+cognitive | 1 |
| 436 | trial-proven | 1 |
| 437 | two-nucleoside | 1 |
| 438 | v.a.c.® | 1 |
| 439 | vaniprevir-containing | 1 |
| 440 | verapamil-based | 1 |
| 441 | visual-probe | 1 |
| 442 | weed-management | 1 |
| 443 | weekly/monthly | 1 |
| 444 | word-search | 1 |
| 445 | zdv-containing | 1 |
| 1 | 'individualized | 2 |
| 2 | 'mindfulness | 1 |
| 3 | 'petra | 1 |
| 4 | 'talking | 4 |
| 5 | 'triple | 14 |
| 6 | 0.8× | 1 |
| 7 | 1470±690 | 1 |
| 8 | 16-min | 1 |
| 9 | 1q25.3/1p35.2 | 1 |
| 10 | 2-drug | 14 |
| 11 | 2-strand | 3 |
| 12 | 2.0-s-long | 1 |
| 13 | 20-mg/kg/day | 2 |
| 14 | 21-7 | 1 |
| 15 | 3-drug | 33 |
| 16 | 3tc-based | 1 |
| 17 | 4-drug | 16 |
| 18 | 4-mm-diameter | 3 |
| 19 | 5-drug | 11 |
| 20 | 5-mci | 1 |
| 21 | a/cd36 | 1 |
| 22 | aa'3b4o12-type | 1 |
| 23 | abl/src | 1 |
| 24 | accelerated-dose | 1 |
| 25 | advagraf®-based | 1 |
| 26 | advocate®/advantage® | 1 |
| 27 | agent-based | 14 |
| 28 | alfa-2a/rbv | 1 |
| 29 | all-2 | 7 |
| 30 | amphotericin-based | 1 |
| 31 | ampicillin-sulbactam-based | 1 |
| 32 | anesthesiologist-administered | 3 |
| 33 | anthracycline/taxane | 2 |
| 34 | anti-hp | 8 |
| 35 | anti-inflammatory/cardiovascular | 1 |
| 36 | anti-m3 | 1 |
| 37 | antihistamine/decongestant | 5 |
| 38 | aprepitant-based | 1 |
| 39 | arm+leg | 2 |
| 40 | aspirin-based | 3 |
| 41 | asunaprevir-based | 1 |
| 42 | atorvastatin-based | 3 |
| 43 | atzpodien | 3 |
| 44 | auger-type | 2 |
| 45 | auricular-plaster | 2 |
| 46 | awakening-time-treatment | 1 |
| 47 | azi-loaded | 1 |
| 48 | azt-substitution | 6 |
| 49 | b-cell-targeted | 3 |
| 50 | badal | 1 |
| 51 | basal-bolus | 102 |
| 52 | basal-prandial | 8 |
| 53 | basal/bolus | 7 |
| 54 | belatacept-based | 7 |
| 55 | benidipine-based | 2 |
| 56 | bevacizumab+mfolfiri | 5 |
| 57 | bezafibrate-lovastatin | 2 |
| 58 | bioactivity-integrated | 4 |
| 59 | birid | 3 |
| 60 | bismuth-based | 25 |
| 61 | bismuth-containing | 29 |
| 62 | bli-3/tsp-15/doxa-1 | 1 |
| 63 | boceprevir-based | 10 |
| 64 | bpi-based | 1 |
| 65 | c-src/abl | 2 |
| 66 | caffeine-containing | 12 |
| 67 | calcineurin-inhibitor-free | 3 |
| 68 | carbon-neutral | 1 |
| 69 | carotenoid-based | 2 |
| 70 | category-matching | 1 |
| 71 | ccta-directed | 1 |
| 72 | ceramide-dominant | 5 |
| 73 | cfc-containing | 4 |
| 74 | chemotherapy/bevacizumab | 2 |
| 75 | cilostazol-based | 2 |
| 76 | cilostazol-optimized | 2 |
| 77 | cis-platinum-containing | 1 |
| 78 | citrate-based | 10 |
| 79 | clarithromycin-based | 23 |
| 80 | clarithromycin-containing | 2 |
| 81 | clarithromycinbased | 2 |
| 82 | clinician-directed | 8 |
| 83 | clopidogrel-based | 1 |
| 84 | clopidogrel-induced | 5 |
| 85 | clopidogrel-only | 2 |
| 86 | clr-based | 1 |
| 87 | cni-based | 15 |
| 88 | cni-free | 28 |
| 89 | co-60 | 8 |
| 90 | co60 | 2 |
| 91 | codeine-based | 2 |
| 92 | cognitive-depletion | 1 |
| 93 | combinational | 53 |
| 94 | combined-drug | 2 |
| 95 | comedication/augmentation | 1 |
| 96 | componentn | 1 |
| 97 | conbination | 2 |
| 98 | constant-frequency | 7 |
| 99 | continuous-dosing | 3 |
| 100 | continuous-sequential | 1 |
| 101 | cost/treatment | 1 |
| 102 | cox/5-lox | 3 |
| 103 | csa-based | 20 |
| 104 | csa-containing | 2 |
| 105 | cube-like | 2 |
| 106 | culture-guided | 13 |
| 107 | cxcr3-cxcr4 | 1 |
| 108 | cyclosporine-based | 22 |
| 109 | d4t-containing | 2 |
| 110 | darunavir/ritonavir-based | 1 |
| 111 | das-d. | 1 |
| 112 | das28-driven | 1 |
| 113 | dcl2/dcl3/dcl4 | 1 |
| 114 | ddp-based | 1 |
| 115 | decreased/normal | 1 |
| 116 | denominator-their | 1 |
| 117 | depression/drug | 1 |
| 118 | dhp-based | 1 |
| 119 | diadochokinetic | 1 |
| 120 | disparity-discrimination | 1 |
| 121 | dispersed-subtractive | 1 |
| 122 | dolutegravir-containing | 1 |
| 123 | dompé | 2 |
| 124 | drug-intramuscular | 1 |
| 125 | drv/r-based | 9 |
| 126 | dual | 3,372 |
| 127 | dual-agent | 3 |
| 128 | dynamic-dosing | 1 |
| 129 | edahb-mediated | 1 |
| 130 | edta-2k | 1 |
| 131 | efavirenz-containing | 18 |
| 132 | energy-favorable | 1 |
| 133 | epirubicin-cisplatin-infusional | 1 |
| 134 | epoxygenase | 5 |
| 135 | eri-1 | 1 |
| 136 | esomeprazole-based | 8 |
| 137 | esoprazole-based | 3 |
| 138 | everolimus-based | 17 |
| 139 | excipient-free | 1 |
| 140 | exhitbit | 1 |
| 141 | expulsive | 42 |
| 142 | face-rating | 1 |
| 143 | faceted | 3 |
| 144 | fad3fad7fad8 | 1 |
| 145 | faldaprevir-pegifn-rbv | 1 |
| 146 | fc-inactivated | 2 |
| 147 | feature-absent | 5 |
| 148 | feature-listing | 1 |
| 149 | fenofibrate-statin | 9 |
| 150 | fiber/vitamin | 1 |
| 151 | first-generation-pi | 1 |
| 152 | first-person-shooter | 1 |
| 153 | five-drug | 10 |
| 154 | fixed-period | 1 |
| 155 | flanker-stop-signal | 1 |
| 156 | flanker/nogo | 1 |
| 157 | flare-only | 1 |
| 158 | fluid-conservative | 2 |
| 159 | fluid-liberal | 2 |
| 160 | fluoropyrimidine/cisplatin | 1 |
| 161 | fluoroquinolone-containing | 3 |
| 162 | food-reinforcement | 1 |
| 163 | four-drug | 37 |
| 164 | fränkel | 8 |
| 165 | ftbi/vp-16 | 5 |
| 166 | function-learning | 1 |
| 167 | furazolidone-based | 9 |
| 168 | furazolidone-containing | 2 |
| 169 | gap-overlap | 1 |
| 170 | gem-containing | 2 |
| 171 | gemcitabine-containing | 3 |
| 172 | gibbs | 87 |
| 173 | goalkeeping | 1 |
| 174 | gromos96 | 1 |
| 175 | h-re | 3 |
| 176 | hair/plasma | 1 |
| 177 | handrim | 12 |
| 178 | haptic-identification | 1 |
| 179 | heat-generated | 3 |
| 180 | heparin-based | 11 |
| 181 | highly-active | 13 |
| 182 | hill-walking | 1 |
| 183 | hivnet-012 | 8 |
| 184 | hnis/tdtomato | 3 |
| 185 | house-matching | 1 |
| 186 | hsc-mediated | 2 |
| 187 | hsfa1a/b/d | 2 |
| 188 | hsfa1a/b/d/e | 2 |
| 189 | i-one | 9 |
| 190 | ics-laba | 3 |
| 191 | il28β-guided | 1 |
| 192 | imidapril-based | 2 |
| 193 | imidazole-based | 2 |
| 194 | immunsuppressive | 1 |
| 195 | indefinite-term | 1 |
| 196 | infusion-only | 1 |
| 197 | inh+emb-based | 2 |
| 198 | inter-association | 1 |
| 199 | isdn/hyd | 13 |
| 200 | isoniazid-based | 2 |
| 201 | j-tech | 1 |
| 202 | juice-making | 2 |
| 203 | lamivudine-plus-adefovir | 3 |
| 204 | lansoprazole-based | 7 |
| 205 | ldl-c/non-hdl | 1 |
| 206 | letter-updating | 1 |
| 207 | levofloxacin-250 | 2 |
| 208 | levofloxacin-based | 41 |
| 209 | levofloxacin-containing | 25 |
| 210 | levofloxacin-free | 1 |
| 211 | levofloxacin-tinidazole-based | 1 |
| 212 | levofloxacin/amoxicillin/esomeprazole | 4 |
| 213 | levofloxacin/amoxicillin/proton-pump | 1 |
| 214 | lexical-decision | 1 |
| 215 | light-to-electric | 2 |
| 216 | list-learning | 2 |
| 217 | liver-directed | 4 |
| 218 | local-selection | 1 |
| 219 | locomotion-to-reach | 1 |
| 220 | lopinavir/ritonavir-containing | 8 |
| 221 | low-activity | 12 |
| 222 | lpv-r/ral | 6 |
| 223 | lt4-lt3 | 3 |
| 224 | lx4211-mediated | 1 |
| 225 | m05-2x/cc-pvtz | 1 |
| 226 | macrolide-based | 4 |
| 227 | magnesium-sufentanil | 1 |
| 228 | magnitude-comparison | 1 |
| 229 | mallinson | 9 |
| 230 | maraviroc-containing | 6 |
| 231 | marbocyl | 4 |
| 232 | mb-based | 2 |
| 233 | mdcf | 18 |
| 234 | mdr/non-mdr | 1 |
| 235 | melphalan-alone | 1 |
| 236 | meop | 1 |
| 237 | mericitabine-containing | 1 |
| 238 | metformin+pioglitazone+glibenclamide | 1 |
| 239 | methylaminolaevulinate | 2 |
| 240 | metronidazole-containing | 5 |
| 241 | metronidazole.a | 1 |
| 242 | micro-electrical | 1 |
| 243 | midazolam-based | 3 |
| 244 | monotherapy.the | 2 |
| 245 | more-predictable | 1 |
| 246 | morphine-promethazine | 1 |
| 247 | moxifloxacin-based | 17 |
| 248 | moxifloxacin-containing | 10 |
| 249 | multi | 155 |
| 250 | multi-treatment | 4 |
| 251 | multiplate-tailored | 2 |
| 252 | multiple-object-tracking | 1 |
| 253 | multisystemic | 84 |
| 254 | multitarget | 23 |
| 255 | narrow-window | 2 |
| 256 | navel-warming | 8 |
| 257 | neoadjuvant/adjuvant/chemoprevention | 1 |
| 258 | nevirapine-containing | 3 |
| 259 | niacin-statin | 3 |
| 260 | nightwork | 1 |
| 261 | nnrti-containing | 8 |
| 262 | non-anaphylactogenic | 2 |
| 263 | non-basal | 1 |
| 264 | non-bismuth | 20 |
| 265 | non-bismuth-based | 1 |
| 266 | non-cag | 4 |
| 267 | non-cns-t | 2 |
| 268 | non-continuous | 9 |
| 269 | non-hbv-active | 2 |
| 270 | non-infiltrative | 2 |
| 271 | non-ketamine-containing | 1 |
| 272 | non-mdr | 6 |
| 273 | non-platinum/non-taxane | 1 |
| 274 | non-pld | 1 |
| 275 | non-sena | 4 |
| 276 | non-thermal-based | 1 |
| 277 | nonbismuth | 4 |
| 278 | noncaffeinated | 10 |
| 279 | nonefavirenz-based | 2 |
| 280 | nonfurazolidone | 1 |
| 281 | nonnewer | 1 |
| 282 | nonthienopyridine | 1 |
| 283 | nrti-based | 2 |
| 284 | nrti-sparing | 12 |
| 285 | ntrti-sparing | 5 |
| 286 | nursing-implemented | 6 |
| 287 | ocd-specific | 2 |
| 288 | opicapone-induced | 2 |
| 289 | outcomes.balanced | 1 |
| 290 | p-containing | 7 |
| 291 | paired-click | 1 |
| 292 | parasitism-adapted | 1 |
| 293 | pdxg | 1 |
| 294 | peg-ifn/ribavirin | 10 |
| 295 | peg-ifna/rbv | 1 |
| 296 | peg/lam | 1 |
| 297 | penicillin-aminoglycoside | 2 |
| 298 | perturbative | 13 |
| 299 | pfdhfr/pfdhps | 1 |
| 300 | photofrin | 5 |
| 301 | photofrin-mediated | 1 |
| 302 | physical/occupational | 6 |
| 303 | pi/r-based | 5 |
| 304 | picture-definition | 1 |
| 305 | picture-perception | 1 |
| 306 | pill-based | 3 |
| 307 | plus/luxacore | 1 |
| 308 | pmdi-spacer | 1 |
| 309 | polar×semipolar | 2 |
| 310 | polysporin | 16 |
| 311 | ppi-amoxicillin-levofloxacin | 1 |
| 312 | ppi-based | 22 |
| 313 | ppi-clarithromycin-metronidazole | 1 |
| 314 | ppi-triple | 1 |
| 315 | praise-related | 1 |
| 316 | prasugrel-based | 2 |
| 317 | pre-highly-active | 1 |
| 318 | pritchard | 8 |
| 319 | probability-trade-off | 1 |
| 320 | proline-induced | 2 |
| 321 | purevision™ | 1 |
| 322 | pushing/pulling | 1 |
| 323 | quadruple | 348 |
| 324 | quinine-based | 2 |
| 325 | rabeprazole-based | 5 |
| 326 | radio/chemoradiotherapy | 1 |
| 327 | radiotherapy-hyperthermia | 2 |
| 328 | raltegravir-containing | 1 |
| 329 | raltegravir-inclusive | 1 |
| 330 | rbv-free | 5 |
| 331 | reach-and-return | 1 |
| 332 | remittive | 4 |
| 333 | renin- | 3 |
| 334 | resistance-guided | 2 |
| 335 | resonance-type | 3 |
| 336 | response-priming | 1 |
| 337 | restrictive-deferred | 1 |
| 338 | reversal/extinction | 1 |
| 339 | rh-endostatin+dp | 2 |
| 340 | ribavirin-containing | 7 |
| 341 | ribavirin-free | 8 |
| 342 | rifabutin-amoxicillin-ppi | 1 |
| 343 | rifampin-containing | 6 |
| 344 | ritonavir-containing | 3 |
| 345 | rmp-containing | 4 |
| 346 | rsv/rv | 4 |
| 347 | rtv-sparing | 3 |
| 348 | sanità-pulsed | 2 |
| 349 | sarpogrelate-based | 1 |
| 350 | schema-focused | 14 |
| 351 | self-affirmation/control | 1 |
| 352 | sequential-concomitant | 2 |
| 353 | serotonin-preferring | 1 |
| 354 | sham‟ | 1 |
| 355 | shoma | 1 |
| 356 | shu-needle | 9 |
| 357 | side-step-cutting | 1 |
| 358 | single-drug | 69 |
| 359 | single/dual | 2 |
| 360 | sirolimus-based | 17 |
| 361 | six-drug | 4 |
| 362 | six-pulse | 1 |
| 363 | smartmix | 1 |
| 364 | smoking-craving | 1 |
| 365 | smtp-7-induced | 1 |
| 366 | solvatoemissive | 1 |
| 367 | spatial-context-discrimination | 1 |
| 368 | specific-sprinter | 1 |
| 369 | src/abl1 | 1 |
| 370 | srl-based | 11 |
| 371 | ssri+t3 | 2 |
| 372 | star-tracing | 1 |
| 373 | statin-based | 16 |
| 374 | statin-fenofibrate | 5 |
| 375 | statin-fibrate | 37 |
| 376 | statin-niacin | 2 |
| 377 | stavudine-containing | 7 |
| 378 | steroid-avoiding | 2 |
| 379 | sti-shiv | 1 |
| 380 | sti-treatment | 1 |
| 381 | strong-coupling | 4 |
| 382 | subcitrate-based | 1 |
| 383 | sulfonylurea-based | 6 |
| 384 | surf- | 1 |
| 385 | sustained-attention-to-response | 1 |
| 386 | symbol-disambiguation | 1 |
| 387 | symbol-learning | 1 |
| 388 | symptom-guided | 23 |
| 389 | synchronization-continuation | 1 |
| 390 | t-cell-directed | 2 |
| 391 | t3-ssri | 2 |
| 392 | t3-ssris | 1 |
| 393 | t4/t3 | 6 |
| 394 | ta-based | 1 |
| 395 | tac-based | 13 |
| 396 | tacrolimus-based | 33 |
| 397 | tactile-proprioceptive | 1 |
| 398 | tamoxifen/everolimus | 2 |
| 399 | taste-rating | 1 |
| 400 | taxane-anthracycline-capecitabine | 2 |
| 401 | taxane-platinum | 11 |
| 402 | tdf-containing | 8 |
| 403 | tdf/ftc-based | 3 |
| 404 | telaprevir-based | 28 |
| 405 | telemetry-enabled | 1 |
| 406 | temperature-time | 18 |
| 407 | temsirolimus-containing | 1 |
| 408 | tenofovir-based | 16 |
| 409 | testing.a | 1 |
| 410 | thalidomide-containing | 4 |
| 411 | thienopyridine-based | 1 |
| 412 | three-drug | 84 |
| 413 | thrombin-specific | 2 |
| 414 | thymidine-sparing | 2 |
| 415 | time-based | 39 |
| 416 | time-estimation | 1 |
| 417 | tomatis | 5 |
| 418 | tower-of-hanoi | 1 |
| 419 | treatment+cognitive | 1 |
| 420 | trial-proven | 1 |
| 421 | triple | 2,423 |
| 422 | triple-agent | 3 |
| 423 | triple-drug | 59 |
| 424 | triple-nucleoside | 2 |
| 425 | tvr-based | 9 |
| 426 | two-drug | 73 |
| 427 | two-nucleoside | 1 |
| 428 | udca-same | 6 |
| 429 | underdoped | 3 |
| 430 | uv-based | 3 |
| 431 | v.a.c.® | 1 |
| 432 | vaniprevir-containing | 1 |
| 433 | vascular-targeted | 4 |
| 434 | verapamil-based | 1 |
| 435 | verteporfin-based | 2 |
| 436 | visual-probe | 1 |
| 437 | weed-management | 1 |
| 438 | weekly/monthly | 1 |
| 439 | word-search | 1 |
| 440 | yuzpe | 41 |
| 441 | zdv-containing | 1 |
| 442 | zero-point | 14 |
| 443 | zidovudine-based | 7 |
| 444 | zidovudine-containing | 7 |
| 445 | β-blocker-based | 4 |
| 1 | surf- | 1 |
| 2 | renin- | 3 |
| 3 | das-d. | 1 |
| 4 | levofloxacin-250 | 2 |
| 5 | co-60 | 8 |
| 6 | co60 | 2 |
| 7 | 1470±690 | 1 |
| 8 | bli-3/tsp-15/doxa-1 | 1 |
| 9 | eri-1 | 1 |
| 10 | src/abl1 | 1 |
| 11 | all-2 | 7 |
| 12 | 1q25.3/1p35.2 | 1 |
| 13 | hivnet-012 | 8 |
| 14 | anti-m3 | 1 |
| 15 | ssri+t3 | 2 |
| 16 | t4/t3 | 6 |
| 17 | lt4-lt3 | 3 |
| 18 | dcl2/dcl3/dcl4 | 1 |
| 19 | cxcr3-cxcr4 | 1 |
| 20 | ftbi/vp-16 | 5 |
| 21 | a/cd36 | 1 |
| 22 | gromos96 | 1 |
| 23 | 21-7 | 1 |
| 24 | fad3fad7fad8 | 1 |
| 25 | metronidazole.a | 1 |
| 26 | testing.a | 1 |
| 27 | ics-laba | 3 |
| 28 | radiotherapy-hyperthermia | 2 |
| 29 | shoma | 1 |
| 30 | hair/plasma | 1 |
| 31 | non-sena | 4 |
| 32 | 'petra | 1 |
| 33 | chemotherapy/bevacizumab | 2 |
| 34 | ocd-specific | 2 |
| 35 | thrombin-specific | 2 |
| 36 | multisystemic | 84 |
| 37 | non-anaphylactogenic | 2 |
| 38 | light-to-electric | 2 |
| 39 | diadochokinetic | 1 |
| 40 | abl/src | 1 |
| 41 | hsfa1a/b/d | 2 |
| 42 | outcomes.balanced | 1 |
| 43 | smtp-7-induced | 1 |
| 44 | proline-induced | 2 |
| 45 | opicapone-induced | 2 |
| 46 | clopidogrel-induced | 5 |
| 47 | azi-loaded | 1 |
| 48 | resistance-guided | 2 |
| 49 | culture-guided | 13 |
| 50 | symptom-guided | 23 |
| 51 | il28β-guided | 1 |
| 52 | telemetry-enabled | 1 |
| 53 | underdoped | 3 |
| 54 | anesthesiologist-administered | 3 |
| 55 | multiplate-tailored | 2 |
| 56 | restrictive-deferred | 1 |
| 57 | sulfonylurea-based | 6 |
| 58 | csa-based | 20 |
| 59 | ta-based | 1 |
| 60 | mb-based | 2 |
| 61 | inh+emb-based | 2 |
| 62 | tac-based | 13 |
| 63 | 3tc-based | 1 |
| 64 | tdf/ftc-based | 3 |
| 65 | carotenoid-based | 2 |
| 66 | isoniazid-based | 2 |
| 67 | macrolide-based | 4 |
| 68 | imidazole-based | 2 |
| 69 | levofloxacin-tinidazole-based | 1 |
| 70 | rabeprazole-based | 5 |
| 71 | esomeprazole-based | 8 |
| 72 | esoprazole-based | 3 |
| 73 | lansoprazole-based | 7 |
| 74 | time-based | 39 |
| 75 | thienopyridine-based | 1 |
| 76 | zidovudine-based | 7 |
| 77 | codeine-based | 2 |
| 78 | quinine-based | 2 |
| 79 | benidipine-based | 2 |
| 80 | cyclosporine-based | 22 |
| 81 | furazolidone-based | 9 |
| 82 | sarpogrelate-based | 1 |
| 83 | citrate-based | 10 |
| 84 | subcitrate-based | 1 |
| 85 | bismuth-based | 25 |
| 86 | non-bismuth-based | 1 |
| 87 | cni-based | 15 |
| 88 | bpi-based | 1 |
| 89 | ppi-based | 22 |
| 90 | nrti-based | 2 |
| 91 | non-thermal-based | 1 |
| 92 | clopidogrel-based | 1 |
| 93 | prasugrel-based | 2 |
| 94 | verapamil-based | 1 |
| 95 | imidapril-based | 2 |
| 96 | pill-based | 3 |
| 97 | cilostazol-based | 2 |
| 98 | srl-based | 11 |
| 99 | midazolam-based | 3 |
| 100 | ampicillin-sulbactam-based | 1 |
| 101 | moxifloxacin-based | 17 |
| 102 | levofloxacin-based | 41 |
| 103 | amphotericin-based | 1 |
| 104 | clarithromycin-based | 23 |
| 105 | verteporfin-based | 2 |
| 106 | heparin-based | 11 |
| 107 | aspirin-based | 3 |
| 108 | statin-based | 16 |
| 109 | atorvastatin-based | 3 |
| 110 | ddp-based | 1 |
| 111 | dhp-based | 1 |
| 112 | pi/r-based | 5 |
| 113 | drv/r-based | 9 |
| 114 | β-blocker-based | 4 |
| 115 | darunavir/ritonavir-based | 1 |
| 116 | telaprevir-based | 28 |
| 117 | asunaprevir-based | 1 |
| 118 | boceprevir-based | 10 |
| 119 | tenofovir-based | 16 |
| 120 | clr-based | 1 |
| 121 | tvr-based | 9 |
| 122 | tacrolimus-based | 33 |
| 123 | everolimus-based | 17 |
| 124 | sirolimus-based | 17 |
| 125 | aprepitant-based | 1 |
| 126 | agent-based | 14 |
| 127 | belatacept-based | 7 |
| 128 | uv-based | 3 |
| 129 | nonefavirenz-based | 2 |
| 130 | advagraf®-based | 1 |
| 131 | clarithromycinbased | 2 |
| 132 | sanità-pulsed | 2 |
| 133 | schema-focused | 14 |
| 134 | lx4211-mediated | 1 |
| 135 | edahb-mediated | 1 |
| 136 | hsc-mediated | 2 |
| 137 | photofrin-mediated | 1 |
| 138 | praise-related | 1 |
| 139 | noncaffeinated | 10 |
| 140 | heat-generated | 3 |
| 141 | bioactivity-integrated | 4 |
| 142 | fc-inactivated | 2 |
| 143 | ccta-directed | 1 |
| 144 | t-cell-directed | 2 |
| 145 | clinician-directed | 8 |
| 146 | liver-directed | 4 |
| 147 | faceted | 3 |
| 148 | b-cell-targeted | 3 |
| 149 | vascular-targeted | 4 |
| 150 | nursing-implemented | 6 |
| 151 | parasitism-adapted | 1 |
| 152 | 'individualized | 2 |
| 153 | cilostazol-optimized | 2 |
| 154 | birid | 3 |
| 155 | non-pld | 1 |
| 156 | 2-strand | 3 |
| 157 | fixed-period | 1 |
| 158 | pritchard | 8 |
| 159 | isdn/hyd | 13 |
| 160 | hsfa1a/b/d/e | 2 |
| 161 | visual-probe | 1 |
| 162 | metformin+pioglitazone+glibenclamide | 1 |
| 163 | penicillin-aminoglycoside | 2 |
| 164 | triple-nucleoside | 2 |
| 165 | two-nucleoside | 1 |
| 166 | cni-free | 28 |
| 167 | levofloxacin-free | 1 |
| 168 | ribavirin-free | 8 |
| 169 | calcineurin-inhibitor-free | 3 |
| 170 | excipient-free | 1 |
| 171 | rbv-free | 5 |
| 172 | monotherapy.the | 2 |
| 173 | cube-like | 2 |
| 174 | energy-favorable | 1 |
| 175 | more-predictable | 1 |
| 176 | shu-needle | 9 |
| 177 | ppi-clarithromycin-metronidazole | 1 |
| 178 | levofloxacin/amoxicillin/esomeprazole | 4 |
| 179 | triple | 2,423 |
| 180 | 'triple | 14 |
| 181 | ppi-triple | 1 |
| 182 | quadruple | 348 |
| 183 | udca-same | 6 |
| 184 | temperature-time | 18 |
| 185 | non-platinum/non-taxane | 1 |
| 186 | anthracycline/taxane | 2 |
| 187 | taxane-anthracycline-capecitabine | 2 |
| 188 | nonthienopyridine | 1 |
| 189 | morphine-promethazine | 1 |
| 190 | i-one | 9 |
| 191 | nonfurazolidone | 1 |
| 192 | melphalan-alone | 1 |
| 193 | aa'3b4o12-type | 1 |
| 194 | resonance-type | 3 |
| 195 | auger-type | 2 |
| 196 | yuzpe | 41 |
| 197 | h-re | 3 |
| 198 | plus/luxacore | 1 |
| 199 | epoxygenase | 5 |
| 200 | six-pulse | 1 |
| 201 | sustained-attention-to-response | 1 |
| 202 | accelerated-dose | 1 |
| 203 | methylaminolaevulinate | 2 |
| 204 | statin-fibrate | 37 |
| 205 | statin-fenofibrate | 5 |
| 206 | expulsive | 42 |
| 207 | immunsuppressive | 1 |
| 208 | solvatoemissive | 1 |
| 209 | raltegravir-inclusive | 1 |
| 210 | perturbative | 13 |
| 211 | non-infiltrative | 2 |
| 212 | fluid-conservative | 2 |
| 213 | non-hbv-active | 2 |
| 214 | highly-active | 13 |
| 215 | pre-highly-active | 1 |
| 216 | dispersed-subtractive | 1 |
| 217 | treatment+cognitive | 1 |
| 218 | tactile-proprioceptive | 1 |
| 219 | remittive | 4 |
| 220 | mdcf | 18 |
| 221 | probability-trade-off | 1 |
| 222 | non-cag | 4 |
| 223 | arm+leg | 2 |
| 224 | star-tracing | 1 |
| 225 | steroid-avoiding | 2 |
| 226 | house-matching | 1 |
| 227 | category-matching | 1 |
| 228 | juice-making | 2 |
| 229 | multiple-object-tracking | 1 |
| 230 | 'talking | 4 |
| 231 | hill-walking | 1 |
| 232 | pushing/pulling | 1 |
| 233 | strong-coupling | 4 |
| 234 | response-priming | 1 |
| 235 | navel-warming | 8 |
| 236 | csa-containing | 2 |
| 237 | cfc-containing | 4 |
| 238 | maraviroc-containing | 6 |
| 239 | thalidomide-containing | 4 |
| 240 | metronidazole-containing | 5 |
| 241 | mericitabine-containing | 1 |
| 242 | gemcitabine-containing | 3 |
| 243 | stavudine-containing | 7 |
| 244 | zidovudine-containing | 7 |
| 245 | caffeine-containing | 12 |
| 246 | non-ketamine-containing | 1 |
| 247 | nevirapine-containing | 3 |
| 248 | furazolidone-containing | 2 |
| 249 | fluoroquinolone-containing | 3 |
| 250 | tdf-containing | 8 |
| 251 | bismuth-containing | 29 |
| 252 | nnrti-containing | 8 |
| 253 | gem-containing | 2 |
| 254 | cis-platinum-containing | 1 |
| 255 | moxifloxacin-containing | 10 |
| 256 | levofloxacin-containing | 25 |
| 257 | clarithromycin-containing | 2 |
| 258 | rifampin-containing | 6 |
| 259 | ribavirin-containing | 7 |
| 260 | p-containing | 7 |
| 261 | rmp-containing | 4 |
| 262 | ritonavir-containing | 3 |
| 263 | lopinavir/ritonavir-containing | 8 |
| 264 | raltegravir-containing | 1 |
| 265 | dolutegravir-containing | 1 |
| 266 | vaniprevir-containing | 1 |
| 267 | temsirolimus-containing | 1 |
| 268 | d4t-containing | 2 |
| 269 | zdv-containing | 1 |
| 270 | efavirenz-containing | 18 |
| 271 | symbol-learning | 1 |
| 272 | function-learning | 1 |
| 273 | list-learning | 2 |
| 274 | goalkeeping | 1 |
| 275 | thymidine-sparing | 2 |
| 276 | nrti-sparing | 12 |
| 277 | ntrti-sparing | 5 |
| 278 | rtv-sparing | 3 |
| 279 | serotonin-preferring | 1 |
| 280 | dynamic-dosing | 1 |
| 281 | continuous-dosing | 3 |
| 282 | letter-updating | 1 |
| 283 | face-rating | 1 |
| 284 | taste-rating | 1 |
| 285 | feature-listing | 1 |
| 286 | side-step-cutting | 1 |
| 287 | smoking-craving | 1 |
| 288 | 2.0-s-long | 1 |
| 289 | 2-drug | 14 |
| 290 | 3-drug | 33 |
| 291 | 4-drug | 16 |
| 292 | 5-drug | 11 |
| 293 | combined-drug | 2 |
| 294 | three-drug | 84 |
| 295 | single-drug | 69 |
| 296 | triple-drug | 59 |
| 297 | five-drug | 10 |
| 298 | two-drug | 73 |
| 299 | four-drug | 37 |
| 300 | six-drug | 4 |
| 301 | depression/drug | 1 |
| 302 | pdxg | 1 |
| 303 | locomotion-to-reach | 1 |
| 304 | j-tech | 1 |
| 305 | word-search | 1 |
| 306 | non-bismuth | 20 |
| 307 | nonbismuth | 4 |
| 308 | 5-mci | 1 |
| 309 | tower-of-hanoi | 1 |
| 310 | first-generation-pi | 1 |
| 311 | rifabutin-amoxicillin-ppi | 1 |
| 312 | bevacizumab+mfolfiri | 5 |
| 313 | t3-ssri | 2 |
| 314 | multi | 155 |
| 315 | edta-2k | 1 |
| 316 | paired-click | 1 |
| 317 | nightwork | 1 |
| 318 | micro-electrical | 1 |
| 319 | badal | 1 |
| 320 | basal-prandial | 8 |
| 321 | continuous-sequential | 1 |
| 322 | decreased/normal | 1 |
| 323 | flanker-stop-signal | 1 |
| 324 | epirubicin-cisplatin-infusional | 1 |
| 325 | combinational | 53 |
| 326 | physical/occupational | 6 |
| 327 | lpv-r/ral | 6 |
| 328 | fluid-liberal | 2 |
| 329 | carbon-neutral | 1 |
| 330 | non-basal | 1 |
| 331 | dual | 3,372 |
| 332 | single/dual | 2 |
| 333 | c-src/abl | 2 |
| 334 | ldl-c/non-hdl | 1 |
| 335 | fränkel | 8 |
| 336 | magnesium-sufentanil | 1 |
| 337 | self-affirmation/control | 1 |
| 338 | marbocyl | 4 |
| 339 | peg/lam | 1 |
| 340 | handrim | 12 |
| 341 | indefinite-term | 1 |
| 342 | taxane-platinum | 11 |
| 343 | atzpodien | 3 |
| 344 | das28-driven | 1 |
| 345 | trial-proven | 1 |
| 346 | statin-niacin | 2 |
| 347 | ppi-amoxicillin-levofloxacin | 1 |
| 348 | 16-min | 1 |
| 349 | fiber/vitamin | 1 |
| 350 | photofrin | 5 |
| 351 | peg-ifn/ribavirin | 10 |
| 352 | polysporin | 16 |
| 353 | fluoropyrimidine/cisplatin | 1 |
| 354 | fenofibrate-statin | 9 |
| 355 | niacin-statin | 3 |
| 356 | bezafibrate-lovastatin | 2 |
| 357 | lexical-decision | 1 |
| 358 | haptic-identification | 1 |
| 359 | inter-association | 1 |
| 360 | time-estimation | 1 |
| 361 | conbination | 2 |
| 362 | spatial-context-discrimination | 1 |
| 363 | disparity-discrimination | 1 |
| 364 | comedication/augmentation | 1 |
| 365 | symbol-disambiguation | 1 |
| 366 | synchronization-continuation | 1 |
| 367 | local-selection | 1 |
| 368 | reversal/extinction | 1 |
| 369 | cognitive-depletion | 1 |
| 370 | picture-definition | 1 |
| 371 | neoadjuvant/adjuvant/chemoprevention | 1 |
| 372 | picture-perception | 1 |
| 373 | azt-substitution | 6 |
| 374 | magnitude-comparison | 1 |
| 375 | mallinson | 9 |
| 376 | reach-and-return | 1 |
| 377 | componentn | 1 |
| 378 | flanker/nogo | 1 |
| 379 | hnis/tdtomato | 3 |
| 380 | gap-overlap | 1 |
| 381 | rh-endostatin+dp | 2 |
| 382 | anti-hp | 8 |
| 383 | levofloxacin/amoxicillin/proton-pump | 1 |
| 384 | meop | 1 |
| 385 | polar×semipolar | 2 |
| 386 | anti-inflammatory/cardiovascular | 1 |
| 387 | drug-intramuscular | 1 |
| 388 | non-mdr | 6 |
| 389 | mdr/non-mdr | 1 |
| 390 | pmdi-spacer | 1 |
| 391 | 4-mm-diameter | 3 |
| 392 | specific-sprinter | 1 |
| 393 | first-person-shooter | 1 |
| 394 | auricular-plaster | 2 |
| 395 | nonnewer | 1 |
| 396 | denominator-their | 1 |
| 397 | lamivudine-plus-adefovir | 3 |
| 398 | gibbs | 87 |
| 399 | t3-ssris | 1 |
| 400 | tomatis | 5 |
| 401 | pfdhfr/pfdhps | 1 |
| 402 | 'mindfulness | 1 |
| 403 | basal-bolus | 102 |
| 404 | basal/bolus | 7 |
| 405 | tamoxifen/everolimus | 2 |
| 406 | non-continuous | 9 |
| 407 | non-cns-t | 2 |
| 408 | multitarget | 23 |
| 409 | exhitbit | 1 |
| 410 | ceramide-dominant | 5 |
| 411 | sequential-concomitant | 2 |
| 412 | antihistamine/decongestant | 5 |
| 413 | triple-agent | 3 |
| 414 | dual-agent | 3 |
| 415 | food-reinforcement | 1 |
| 416 | weed-management | 1 |
| 417 | awakening-time-treatment | 1 |
| 418 | multi-treatment | 4 |
| 419 | sti-treatment | 1 |
| 420 | cost/treatment | 1 |
| 421 | feature-absent | 5 |
| 422 | zero-point | 14 |
| 423 | faldaprevir-pegifn-rbv | 1 |
| 424 | alfa-2a/rbv | 1 |
| 425 | peg-ifna/rbv | 1 |
| 426 | sti-shiv | 1 |
| 427 | rsv/rv | 4 |
| 428 | narrow-window | 2 |
| 429 | smartmix | 1 |
| 430 | cox/5-lox | 3 |
| 431 | 20-mg/kg/day | 2 |
| 432 | constant-frequency | 7 |
| 433 | weekly/monthly | 1 |
| 434 | flare-only | 1 |
| 435 | clopidogrel-only | 2 |
| 436 | infusion-only | 1 |
| 437 | radio/chemoradiotherapy | 1 |
| 438 | low-activity | 12 |
| 439 | m05-2x/cc-pvtz | 1 |
| 440 | 0.8× | 1 |
| 441 | sham‟ | 1 |
| 442 | purevision™ | 1 |
| 443 | dompé | 2 |
| 444 | v.a.c.® | 1 |
| 445 | advocate®/advantage® | 1 |